Evaluation of Crestor® (rosuvastatin) in daily practice

Study identifier:NIS-CSI-CRE-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Open-label non-interventional evaluation of efficacy of Crestor® (rosuvastatin) in reduction of LDL-cholesterol and cardiovascular risk parameters in patients with hypercholesterolaemia

Medical condition

Hypercholesterolemia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

602

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jan 2007

Primary Completion Date: -

Study Completion Date: 01 Oct 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

CSR-NIS-CSI-CRE-2006-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Slovenia Clinical Study Information

+38615135623

[email protected]

Investigators

Principal Investigator

Matija Cevc

University Medical Center Ljubljana